Reishi mushroom (Ganoderma lucidum) mycelium improved key markers of metabolic syndrome in rats fed a high-fructose diet. Blood sugar exposure dropped by 26%, longer-term glucose damage markers fell by 44%, and liver enzymes linked to fatty liver injury declined by up to 43%. Together, the results point to reishi acting as a metabolic stabilizer under high sugar stress rather than a single-pathway fix.